Align Technology's Patent Claims Rejected by Angelalign Amid Legal Disputes
- Angelalign Technology denies patent infringement claims from Align Technology, calling them baseless and without merit.
- The company emphasizes its commitment to patent compliance and over two decades of innovation in orthodontics.
- Angelalign views ongoing legal challenges as opportunities for growth and to strengthen its reputation in the clear-aligner market.
Angelalign Technology Rebuffs Patent Infringement Allegations Amidst Legal Challenges
Angelalign Technology Inc. (6699.HK) recently confronts serious legal challenges as it vehemently rejects patent infringement claims made by Align Technology Inc. (ALGN). The allegations, characterized by Angelalign as baseless and lacking merit, are part of a broader narrative in the competitive landscape of the clear-aligner market. Rich Hirschland, Angelalign's Chief Commercial Officer and Senior Vice President, emphasizes the company's commitment to patent compliance, highlighting over two decades of innovation in the field. Angelalign is proud of its award-winning products, including the angelButton™, the angelHook, and the A6 mandibular advancement system, which have solidified its reputation for high customer satisfaction and effective clinical solutions.
In the face of ongoing legal disputes, Hirschland remains optimistic about the company's growth trajectory. He asserts that the lawsuits will not impede Angelalign’s progress but may present an opportunity to showcase the company’s successful history. Since its inception in 2003, Angelalign has celebrated delivering 1.5 million smiles to patients globally, a testament to its dedication to innovation and high-quality service in the orthodontics sector. The company’s flexible manufacturing system is noted for its capacity to transform complex clinical concepts into practical applications, benefiting both dental practitioners and their patients.
Angelalign is determined to navigate these legal challenges while continuing to lead in the clear-aligner industry. The company’s positive corporate culture, which prioritizes the well-being of employees and customers, is integral to its global expansion strategy. Hirschland underscores that Angelalign views these legal proceedings not merely as obstacles but as opportunities to attract new customers and further establish its reputation as a leader in digitally-driven orthodontic solutions.
In addition to its commitment to innovation, Angelalign continues to focus on fostering healthy competition within the dental market. This approach not only enhances the offerings available to dental professionals but also ultimately benefits patients seeking effective orthodontic solutions. The overarching goal remains clear: to provide tailored, high-quality products that meet the evolving needs of both practitioners and consumers while defending the integrity of its brand against legal challenges.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…